Filter
1923
Filtered Results: 1923
Text search:
Economic
burden
of
Tuberculosis
Featured
Recommendations
149
New Publications
567
Language
Document type
No document type
1210
Studies & Reports
381
Guidelines
146
Strategic & Response Plan
82
Manuals
60
Fact sheets
15
Training Material
11
Situation Updates
9
Resource Platforms
5
Infographics
4
Countries / Regions
Global
87
India
80
Kenya
67
Western and Central Europe
65
South Africa
54
Ethiopia
52
Nigeria
43
Uganda
42
Zambia
42
Nepal
37
Liberia
36
Tanzania
36
Malawi
36
Africa
36
Eastern Europe
35
Rwanda
30
Bangladesh
27
Namibia
25
Latin America and the Carribbean
25
Sierra Leone
24
Ghana
24
Myanmar / Burma
24
Asia
24
South–East Asia Region
22
Ukraine
21
Lesotho
21
Cambodia
20
Zimbabwe
15
Philippines
13
Indonesia
13
East and Southern Africa
12
Botswana
11
South Sudan
10
Mozambique
9
Congo, Democratic Republic of
8
Haiti
7
Pakistan
7
West and Central Africa
7
Russia
7
Syria
6
Eastern Europe and Central Asia
6
Guinea
5
Senegal
5
Cameroon
5
Somalia
5
Afghanistan
5
Colombia
5
Venezuela
5
Moldova
5
Burkina Faso
4
Germany
4
Thailand
4
Sudan
4
Peru
4
Eswatini/ Swaziland
4
Yemen
4
Middle East and North Africa
4
Albania
4
North America
4
Jordan
3
Brazil
3
Western Pacific Region
3
Laos
3
Tajikistan
3
Vietnam
3
Lebanon
2
Papua New Guinea
2
Benin
2
Argentina
2
North Macedonia
2
Sri Lanka
2
Chile
2
Armenia
2
Romania
2
Georgia
2
Turkmenistan
2
Jamaica
2
Mali
1
USA
1
Saudi Arabia
1
Iraq
1
Egypt
1
China
1
Central African Republic
1
Burundi
1
Ecuador
1
Bolivia
1
Libya
1
Other region
1
Bhutan
1
Poland
1
Palestine
1
Djibouti
1
Mongolia
1
Southern Africa
1
Timor Leste/ East Timor
1
Qatar
1
Bulgaria
1
Iran
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
812
Public Health
131
Clinical Guidelines
117
Key Resources
49
Women & Child Health
46
Pharmacy & Technologies
16
Capacity Building
13
Annual Report MEDBOX
1
Toolboxes
TB
275
HIV
258
AMR
105
COVID-19
88
Mental Health
63
Global Health Education
53
Planetary Health
50
NCDs
50
Health Financing Toolbox
47
NTDs
31
Rapid Response
28
Caregiver
27
Refugee
25
Disability
23
Conflict
23
Pharmacy
18
Polio
16
Ebola
11
Natural Hazards
8
Cholera
2
Specific Hazards
2
South Sudan
1
Health Financing
1
Recommendations for a public health approach
HIV/AIDS Programme
PLOS Medicine | DOI:10.1371/journal.pmed.1002088 August 23, 2016
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
The report shows that older people are not getting the healthcare treatments they desperately need. The COVID-19 response has disrupted services for non-communicable diseases such as cancer and diabetes, communicable diseases such as malaria, and much-needed services for mental health. Combined with...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed...
This policy brief aims to provide a review of the current progress on implementing the Burkina Faso national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target ...
Annals of Global Health, 87(1), p.30. DOI: http://doi.org/10.5334/aogh.2647
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread,...
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and control should play a vital role in designing policies and strategies for schist...
Schistosomiasis is widely recognized as a disease that is socially determined. An
understanding of the social and behavioural factors linked to disease transmission and
control should play a vital role in designing policies and strategies for schi...
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order ...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update ... the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc).
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and formulation on the Model Lists of Essential Medicines. The Committee evaluated the scientific evidence for comparative effectiveness, safety and cost-effectiveness of the medicines in question. The Committee also considered a review of the therapeutic alternatives for medicines on the Model Lists, and update to the AWaRe classification of antibiotics, and reviews and reports relevant to the selection and use of essential medicines.
Improving the quality of hospital antibiotic use is a major goal of WHO’s global action plan to combat antimicrobial resistance. The WHO Essential Medicines List Access, Watch, and Reserve (AWaRe)...
No Public Health without Refugee and Migrant health.
This report, the first of its kind, creates an evidence base with the aim of catalysing progress towards developing and promoting migrant-sensit...
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guideli...
2016-2018 Early implementation,
This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to our understanding of how antibiotics are used ...
Can J Anesth/J Can Anesth June 2018, Volume 65, Issue 6, pp 698–708
